Hypothesis and Theory
Published on 26 Nov 2013
Current clinical evidence on pioglitazone pharmacogenomics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00147
- 10,868 views
- 22 citations
83 articles related to "Pioglitazone"
Articles
Original Research
Published on 15 Aug 2017
Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2017.00545
- 6,564 views
- 59 citations
Original Research
Published on 02 Dec 2021
The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans
in Metabolic Physiology
Frontiers in Physiology
doi 10.3389/fphys.2021.784391
- 13,918 views
- 31 citations
Original Research
Published on 11 Oct 2022
Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1004617
- 5,330 views
- 13 citations
Original Research
Published on 06 Aug 2018
Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy Pathway
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2018.00851
- 5,487 views
- 43 citations
Original Research
Published on 14 Jul 2022
Pioglitazone, a Peroxisome Proliferator-Activated Receptor-Îł Agonist, Downregulates the Inflammatory Response in Cutaneous Leishmaniasis Patients Without Interfering in Leishmania braziliensis Killing by Monocytes
in Parasite and Host
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2022.884237
- 3,704 views
- 2 citations
Mini Review
Published on 04 Oct 2018
The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2018.01093
- 13,834 views
- 45 citations
Systematic Review
Published on 28 Apr 2021
Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2021.615409
- 31,206 views
- 114 citations
Original Research
Published on 29 Mar 2023
Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2023.1111430
- 26,232 views
- 47 citations
Original Research
Published on 29 Oct 2020
Pioglitazone Ameliorates Gentamicin Ototoxicity by Affecting the TLR and STAT Pathways in the Early Postnatal Organ of Corti
in Non-Neuronal Cells
Frontiers in Cellular Neuroscience
doi 10.3389/fncel.2020.566148
- 4,187 views
- 8 citations
Original Research
Published on 17 Jul 2018
A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2018.00752
- 7,108 views
- 32 citations
Original Research
Published on 21 Dec 2020
Pioglitazone-Mediated Attenuation of Experimental Colitis Relies on Cleaving of Annexin A1 Released by Macrophages
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.591561
- 7,197 views
- 21 citations
Original Research
Published on 08 Oct 2018
Pioglitazone Represents an Effective Therapeutic Target in Preventing Oxidative/Inflammatory Cochlear Damage Induced by Noise Exposure
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2018.01103
- 8,984 views
- 40 citations
Original Research
Published on 08 Aug 2024
Pioglitazone treatment mitigates cardiovascular bioprosthetic degeneration in a chronic kidney disease model
in Integrative and Regenerative Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1412169
- 3,621 views
Study Protocol
Published on 05 Jan 2024
Pioglitazone in spontaneous subarachnoid hemorrhage: study protocol of a multicenter, double-blind, randomized trial (PSSH)
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1323292
- 4,077 views
Original Research
Published on 31 Jul 2019
Does Pioglitazone Lead to Neutrophil Extracellular Traps Formation in Chronic Granulomatous Disease Patients?
in Primary Immunodeficiencies
Frontiers in Immunology
doi 10.3389/fimmu.2019.01739
- 5,980 views
- 17 citations